Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „moderate“
Suchtreffer
Begriffe & Kennungen
Brukinsa · 4.5 · Concomitant use of BRUKINSA and medicinal products that strongly or moderately inhibit CYP3A can increase zanu
Eintrag öffnenBrukinsa · 4.5 · Concomitant use of BRUKINSA and medicinal products that strongly or moderately inhibit CYP3A can increase zanu
Eintrag öffnenBrukinsa · 4.5 · Concomitant use of zanubrutinib and strong or moderate inducers of CYP3A can decrease zanubrutinib plasma conc
Eintrag öffnenBrukinsa · 4.5 · Concomitant use of zanubrutinib and strong or moderate inducers of CYP3A can decrease zanubrutinib plasma conc
Eintrag öffnenBrukinsa · 4.5 · If a moderate CYP3A inhibitor must be used (e.g., erythromycin, ciprofloxacin, diltiazem, dronedarone, flucona
Eintrag öffnenBrukinsa · 4.5 · If a moderate CYP3A inhibitor must be used (e.g., erythromycin, ciprofloxacin, diltiazem, dronedarone, flucona
Eintrag öffnenBrukinsa · 4.5 · Moderate CYP3A inhibitors
Eintrag öffnenBrukinsa · 4.5 · Moderate CYP3A inhibitors
Eintrag öffnenBrukinsa · 4.5 · The coadministration of multiple doses of moderate CYP3A inhibitors fluconazole and diltiazem in patients with
Eintrag öffnenBrukinsa · 4.5 · The coadministration of multiple doses of moderate CYP3A inhibitors fluconazole and diltiazem in patients with
Eintrag öffnenCabazitaxel Accord · 4.5 · Concomitant administration of aprepitant, a moderate CYP3A inhibitor, had no effect on cabazitaxel clearance.
Eintrag öffnenCalquence · 4.5 · Co-administration with moderate CYP3A inhibitors (400 mg fluconazole as single dose or 200 mg isavuconazole as
Eintrag öffnenCalquence · 4.5 · Co-administration with moderate CYP3A inhibitors (400 mg fluconazole as single dose or 200 mg isavuconazole as
Eintrag öffnenCamzyos · 4.5 · CYP2C19 inhibitors The effect of a moderate and strong CYP2C19 inhibitor on the PK of mavacamten was not inves
Eintrag öffnenCamzyos · 4.5 · Discontinuing a moderate or weak inducer while on mavacamten treatment: Decrease mavacamten by one dose level
Eintrag öffnenCamzyos · 4.5 · Discontinuing or decreasing the dose of moderate or weak inducer while on mavacamten treatment: Decrease mavac
Eintrag öffnenCarmustine medac (previously Carmustine Obvius) · 4.5 · Digoxin Concomitant use with digoxin leads to delayed, moderate, suspected, decreased effect of digoxin (due t
Eintrag öffnenCarmustine medac (previously Carmustine Obvius) · 4.8 · 8 Emetogenic potential The emetogenic potential is high at doses >250 mg/m2 and high to moderate in doses ≤250
Eintrag öffnenCatiolanze · 4.8 · 6 Eye disorders Iris Mild to Eyelid Iritis*; Periorbital hyperpigmentati moderate oedema¥; corneal oedema*; an
Eintrag öffnenCavoley · 4.8 · 8 Reversible, mild to moderate elevations in uric acid and alkaline phosphatase, with no associated clinical e
Eintrag öffnen